![]() | Only 14 pages are availabe for public view |
Abstract Disease recurrence is a devastating event after allogeneic hematopoietic stem cell transplantation as treatment for acute leukemia. Median time to relapse is approximately 4 months and the majority of relapses occur within 2 years after transplant. The prognosis is usually poor. Overall 5-year survival of all patients relapsing post-transplant for acute leukemia Evaluation of TIM-3 level is highly monitoring strategy used as minimal residual disease to predict relapse post bone marrow transplant. TIM-3 level post BMT has significant relation with over-all survival and disease free survival in cases of acute leukemia post allograft. |